BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

618 related articles for article (PubMed ID: 17576321)

  • 1. In vitro activities of four antifungal drugs against Trichophyton rubrum isolates exhibiting resistance to fluconazole.
    Santos DA; Hamdan JS
    Mycoses; 2007 Jul; 50(4):286-9. PubMed ID: 17576321
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of broth microdilution antifungal susceptibility testing conditions for Trichophyton rubrum.
    Santos DA; Hamdan JS
    J Clin Microbiol; 2005 Apr; 43(4):1917-20. PubMed ID: 15815018
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of in vitro activities of antifungal drugs and ethanolic extract of propolis against Trichophyton rubrum and T. mentagrophytes by using a microdilution assay.
    Koc AN; Silici S; Ayangil D; Ferahbaş A; Cankaya S
    Mycoses; 2005 May; 48(3):205-10. PubMed ID: 15842339
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro antifungal susceptibility patterns of dermatophyte strains causing tinea unguium.
    Sarifakioglu E; Seçkin D; Demirbilek M; Can F
    Clin Exp Dermatol; 2007 Nov; 32(6):675-9. PubMed ID: 17714532
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determination of susceptibility/resistance to antifungal drugs of Trichophyton mentagrophytes isolates by a macrodilution method.
    Barros ME; Hamdan JS
    Can J Microbiol; 2005 Nov; 51(11):983-7. PubMed ID: 16333338
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of susceptibility of Trichophyton mentagrophytes and Trichophyton rubrum clinical isolates to antifungal drugs using a modified CLSI microdilution method (M38-A).
    Barros MEDS; Santos DA; Hamdan JS
    J Med Microbiol; 2007 Apr; 56(Pt 4):514-518. PubMed ID: 17374893
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Establishing a method of inoculum preparation for susceptibility testing of Trichophyton rubrum and Trichophyton mentagrophytes.
    Santos DA; Barros ME; Hamdan JS
    J Clin Microbiol; 2006 Jan; 44(1):98-101. PubMed ID: 16390955
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro activities of antifungal drugs against dermatophytes isolated in Tokat, Turkey.
    Yenişehirli G; Tunçoğlu E; Yenişehirli A; Bulut Y
    Int J Dermatol; 2013 Dec; 52(12):1557-60. PubMed ID: 24134487
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular typing and antifungal susceptibility of Trichophyton rubrum isolates from patients with onychomycosis pre- and post-treatment.
    de Assis Santos D; de Carvalho Araújo RA; Kohler LM; Machado-Pinto J; Hamdan JS; Cisalpino PS
    Int J Antimicrob Agents; 2007 May; 29(5):563-9. PubMed ID: 17331707
    [TBL] [Abstract][Full Text] [Related]  

  • 10.
    Singh SK; Patwa DK; Tilak R; Das A; Singh TB
    Indian J Dermatol Venereol Leprol; 2019; 85(4):388-392. PubMed ID: 30950409
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antifungal susceptibilities of dermatophytic agents isolated from clinical specimens.
    Cetinkaya Z; Kiraz N; Karaca S; Kulac M; Ciftci IH; Aktepe OC; Altindis M; Kiyildi N; Piyade M
    Eur J Dermatol; 2005; 15(4):258-61. PubMed ID: 16048753
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro methods for antifungal susceptibility testing of Trichophyton spp.
    Barros ME; Santos Dde A; Hamdan JS
    Mycol Res; 2006 Nov; 110(Pt 11):1355-60. PubMed ID: 17070026
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro susceptibility testing of dermatophytes isolated in Goiania, Brazil, against five antifungal agents by broth microdilution method.
    Araújo CR; Miranda KC; Fernandes Ode F; Soares AJ; Silva Mdo R
    Rev Inst Med Trop Sao Paulo; 2009; 51(1):9-12. PubMed ID: 19229384
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro susceptibility testing of amorolfine in pathogenic fungi isolated from dermatomycosis patients in China.
    Li RY; Wan Z; Wang AP; Shen YN; Lu CM; Li M; Xi LY; Liu WD; Zeng FQ
    Mycoses; 2004 Oct; 47(9-10):402-6. PubMed ID: 15504124
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro antifungal oral drug and drug-combination activity against onychomycosis causative dermatophytes.
    Santos DA; Hamdan JS
    Med Mycol; 2006 Jun; 44(4):357-62. PubMed ID: 16772230
    [TBL] [Abstract][Full Text] [Related]  

  • 16. What defines the quality of patient care in tinea pedis?
    Mistik S; Ferahbas A; Koc AN; Ayangil D; Ozturk A
    J Eur Acad Dermatol Venereol; 2006 Feb; 20(2):158-65. PubMed ID: 16441623
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determination of minimum inhibitory concentrations of itraconazole, terbinafine and ketoconazole against dermatophyte species by broth microdilution method.
    Bhatia VK; Sharma PC
    Indian J Med Microbiol; 2015; 33(4):533-7. PubMed ID: 26470960
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antifungal susceptibility testing of Trichophyton rubrum by E-test.
    da Silva Barros ME; de Assis Santos D; Soares Hamdan J
    Arch Dermatol Res; 2007 May; 299(2):107-9. PubMed ID: 17333224
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interlaboratory study of quality control isolates for a broth microdilution method (modified CLSI M38-A) for testing susceptibilities of dermatophytes to antifungals.
    Ghannoum MA; Arthington-Skaggs B; Chaturvedi V; Espinel-Ingroff A; Pfaller MA; Rennie R; Rinaldi MG; Walsh TJ
    J Clin Microbiol; 2006 Dec; 44(12):4353-6. PubMed ID: 17050812
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro susceptibility testing of ciclopirox, terbinafine, ketoconazole and itraconazole against dermatophytes and nondermatophytes, and in vitro evaluation of combination antifungal activity.
    Gupta AK; Kohli Y
    Br J Dermatol; 2003 Aug; 149(2):296-305. PubMed ID: 12932235
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.